Glycogen synthase kinase 3 beta (GSK3b) is highly inactivated in epithelial cancers and is known to inhibit tumor migration and invasion. The zinc-finger-containing transcriptional repressor, Slug, represses E-cadherin transcription and enhances epithelialmesenchymal transition (EMT). In this study, we find that the GSK3b-pSer9 level is associated with the expression of Slug in nonsmall cell lung cancer. GSK3b-mediated phosphorylation of Slug facilitates Slug protein turnover. Proteomic analysis reveals that the carboxyl terminus of Hsc70-interacting protein (CHIP) interacts with wild-type Slug (wtSlug). Knockdown of CHIP stabilizes the wtSlug protein and reduces Slug ubiquitylation and degradation. In contrast, nonphosphorylatable Slug-4SA is not degraded by CHIP. The accumulation of nondegradable Slug may further lead to the repression of E-cadherin expression and promote cancer cell migration, invasion and metastasis. Our findings provide evidence of a de novo GSK3b-CHIP-Slug pathway that may be involved in the progression of metastasis in lung cancer.
INTRODUCTION
Lung cancer is associated with a high metastatic rate, making it the leading cause of cancer deaths worldwide. 1 Metastasis complicates therapeutic treatment as it transforms a locally growing tumor into a systemic disease that is resistant to existing therapeutic agents. [2] [3] [4] In the first step of metastasis, which is termed invasion, tumor cells dissociate and migrate from the primary tumors. 5 Such a process is controlled by multiple cellular and molecular signaling pathways that together change cell adhesion and migration. This change is known as the epithelial-mesenchymal transition (EMT). 5, 6 E-cadherin-mediated intercellular junctions tightly knit epithelial cells together and prevent them from dissociating. Therefore, suppression of E-cadherin is critical for EMT and is associated with the development of malignant epithelial cancers. [7] [8] [9] [10] A fundamental mechanism that downregulates the expression of E-cadherin during tumor progression is transcriptional repression. 5 Slug (also known as SNAI2), a zinc-finger transcriptional repressor of the Snail family, has been shown to repress E-cadherin expression and trigger EMT. 11, 12 Recently, we have demonstrated the importance of the Slug-E-cadherin axis in nonsmall cell lung cancers (NSCLCs) where aberrant upregulation of Slug promotes cancer invasion and malignant transformation. [13] [14] [15] However, less is known about the regulation of Slug by posttranslational modification in lung cancer. 16 Hence, it is of critical interest to investigate the scenario in which Slug is posttranslationally regulated. To date, phosphorylation and ubiquitylation have been shown to modify numerous transcriptional repressors, such as Snail, nuclear factor-kB and cAMP response element-binding protein, and so on. [17] [18] [19] We postulated that Slug, as a labile protein, may undergo phosphorylationdependent degradation as well.
The carboxyl terminus of Hsc70-interacting protein (CHIP) is a U-box-type ubiquitin ligase that was originally identified to be associated with Hsp70 and Hsp90 chaperones, and to target misfolded proteins for degradation. [20] [21] [22] [23] Accumulating evidence has suggested that CHIP also regulates oncogenic pathways as it induces ubiquitylation and degradation of several oncogenic proteins, such as cystic fibrosis transmembrane conductance regulator, estrogen receptor and ErbB2. [24] [25] [26] [27] Some of the substrates require phosphorylation before degradation. 28 Phosphorylated tau, for example, is mainly ubiquitylated by CHIP and overexpression of CHIP can rescue phosphorylated tauinduced cell death. 29, 30 The serine/threonine kinase, glycogen synthase kinase 3 beta (GSK3b), is involved in regulating the stability of various oncogenic transcriptional factors by phosphorylation. [31] [32] [33] [34] [35] [36] Signaling pathways that inactivate GSK3b, such as phosphatidylinositol 3 kinase/Akt and mitogen-activated protein kinase, may promote the cell cycle, anti-apoptosis and invasion, thus facilitating tumor progression. [37] [38] [39] [40] [41] Indeed, inactivation of GSK3b has been observed in various tumors. [42] [43] [44] [45] Here by proteomic study, we show that Slug proteins can be post-translationally modified by GSK3b and later ubiquitylated by the E3 ligase, CHIP, for proteasomal degradation in lung cancer. Dysregulation of the GSK3b-CHIPSlug pathway may lead to the accumulation of nondegradable Slug and display higher invasive capabilities, which may promote cancer metastasis.
RESULTS

The activity of GSK3b inversely correlates with Slug protein levels
To elucidate whether the activity of GSK3b correlates with Slug expression, we treated A549 cells and HOP62 cells with recombinant epidermal growth factor (EGF) or serum-free medium and analyzed Slug levels by immunoblotting. It has been indicated that Ser9 phosphorylation renders GKS3b an inactive kinase and Relative Invasion (%) EGF -P < 0.01
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Relative Migration (%) unphosphorylation, an active one. 46 We found that the treatment of elevated EGF caused the suppression of GSK3b (through phosphorylation of Ser9) by the activation of Akt and a marked increase in Slug protein levels (Figure 1e ). The reduction in E-cadherin and upregulation of vimentin were accompanied by a spindle-like morphological change (Figure 1e ; Supplementary  Figure 1a , upper panel), increased migration and invasion (Figures 1a and b) . Blockage of the EGF-activated signaling pathways with an Akt inhibitor, LY294002, reduced Ser9 phosphorylation on GSK3b, leading to the elevated activity of GSK3b, the decreased Slug protein levels (Supplementary Figure 1c,  lane 3) , and the retraction of filopodia (Supplementary Figure 1b) . To investigate whether the GSK3b activity is required for the EGFmediated effects on cell morphology and Slug destabilization, we added GSK3b inhibitor VIII in EGF-treated cells and found that the Slug protein levels were accumulated (Supplementary Figure 1c the activation of GSK3b and a conspicuous decrease in Slug protein levels (Figure 1f ). Serum-starved cells aggregated locally (Supplementary Figure 1a , lower panel) and manifested reduced migration and invasion (Figures 1c and d) . The inverse correlation between the GSK3b activity and Slug protein levels was also observed in another lung adenocarcinoma cell line (CL1-5) (Supplementary Figures 1d-f ). These data indicate that mitogen-stimulated pathways can regulate the activity of GSK3b and influence cell migration and invasion. We inferred that the inverse correlation between the activity of GSK3b and the expression of Slug suggests that GSK3b may in turn regulate the expression of Slug.
GSK3b-mediated Slug phosphorylation affects Slug protein turnover To further investigate whether GSK3b regulates the turnover of Slug, CL1-5 cells were treated with GSK3b inhibitor VIII with or without MG132, an inhibitor of the 26S proteasome. Both GSK3b and proteasome inhibition resulted in increased Slug steady-state protein levels (Figure 2a) . Ectopically produced Flag-tagged Slug also accumulated in cells treated with the GSK3b inhibitor ( Supplementary Figure 2a) , suggesting that Slug may be regulated by GSK3b in a transcription-independent manner. In confirmation of this observation, GSK3b-specific short hairpin RNAs (shRNAs) were transduced into cells and the knockdown of GSK3b stabilized endogenous Slug proteins without a significant change in Slug mRNA levels ( Supplementary Figures 2b-e) . Although GSK3a and GSK3b are structurally similar, we did not detect any effect of GSK3a on Slug using GSK3a-specific shRNAs ( Supplementary  Figures 2g and h ). These data suggest that Slug may be regulated by GSK3b-dependent post-translational modification and later targeted for proteasome degradation.
Next, we determined whether GSK3b and Slug could form a complex in vivo. We overexpressed GSK3b and Slug proteins in H1299 cells. Interactions between ectopically expressed GSK3b and Slug were detected in vivo (Supplementary Figure 2i) . Complex formation between endogenous Slug and GSK3b was demonstrated by co-immunoprecipitation ( Figure 2b ). To clarify whether GSK3b mediates Slug phosphorylation directly, we performed the in vitro kinase assay using recombinant GSK3b and glutathione S-transferase (GST)-tagged Slug purified from Escherichia coli (Supplementary Figure 3a) . GSK3b dose-dependently phosphorylated Slug and the phosphorylation sites were further determined by liquid chromatography-tandem mass spectrometry ( Supplementary Figure 3b and c). Interestingly, two serine sites were identified that matched the consensus GSK3b phosphorylation motif whereas in silico analysis predicted two more within this region. To confirm the phosphorylation sites, we constructed and purified bacterially or cellularly expressed Slug mutants as the substrates in the in vitro kinase assay. We found that phosphorylation on GST-S104A and GST-S100/104A mutants was equivalently reduced while that on GST-S92/96A was obviously retained, indicating that Slug was sequentially phosphorylated by GSK3b (Figure 2c , Supplementary Discussion). Kinase-refractile substitutions of alanine for serine at positions 92, 96, 100 and 104 (4SA) displayed markedly reduced levels of phosphorylation in vitro, whereas single or double mutations (except for GST-S104A and GST-S100/104A) partially reduced phosphorylation ( Figure 2c; Supplementary Figure 3d ). We therefore reasoned that the 4SA mutant may better represent the nonphosphorylated status of Slug. Noticeably, phosphorylation of wildtype Slug (wtSlug) also occurred in vivo and was enhanced by the co-expression of constitutively active GSK3b (GSK3b-CA) as determined by the in vivo kinase assay (Supplementary Figure 3e) . Slug-4SA was marginally increased in the presence of GSK3b-CA and we speculated that the nonspecific phosphorylation in Slug-4SA may have been caused by the robust activity of GSK3b-CA. These data suggest that Slug interacts with GSK3b and is phosphorylated by GSK3b at four sequential sites.
To examine whether GSK3b affects Slug stability, we expressed elevated levels of GSK3b-CA with Slug-WT or Slug-4SA mutant. Expression of wtSlug was dose-dependently depleted whereas the 4SA mutant was more resistant to such depletion ( Figure 2d ). In further confirmation of the negative regulation of Slug by GSK3b, we blocked de novo protein synthesis with cycloheximide in cells overexpressing Flag-tagged Slug with either GSK3b-CA or kinase-inactive GSK3b (GSK3b-KD) and analyzed the amount of Slug protein by immunoblotting. Active GSK3b markedly facilitated Slug protein turnover; however, inactive GSK3b did not, as the amount of Slug protein was still abundant at 6 h after cycloheximide treatment (Figure 2e ). In support of this, knockdown of GSK3b resulted in an extension of the half-life of endogenous Slug (Supplementary Figure 2f) . To determine whether GSK3b enhances Slug protein turnover through phosphorylation, we compared the half-life of wtSlug with that of the nonphosphorylatable Slug-4SA. As chased by cycloheximide, the half-life of the 4SA mutant was approximately two times longer than that of wtSlug ( Figure 2f ). Consistent with its longer half-life, Slug-4SA was less ubiquitylated than Slug-WT (Supplementary Figure 2j) . These results suggest that the activity of GSK3b limits the intracellular concentration of Slug and modulates Slug protein turnover by direct phosphorylation.
Phosphorylation of Slug by GSK3b promotes CHIP-binding and ubiquitin-mediated proteolysis As Slug is unstable when phosphorylated, we hypothesized that an unknown ubiquitin ligase may regulate Slug turnover. To identify the ligase, we performed co-immunoprecipitation and mass spectrometry using Flag-tagged wtSlug in the presence or absence of a GSK3b inhibitor (Figures 3a and b) . We used the SAINT method to compute the interaction probabilities among each group 47 and the interactors that had a higher association probability in the Slug alone group than that in the Slug þ inhibitor group are shown in Figure 3c . We found that Slug without GSK3b phosphorylation inhibition was associated with more subunits of proteasomes after MG132 treatment, indicating that the Slug protein is truly labile by proteasomal degradation (Figure 3c ). Among several Slug-interacting proteins, CHIP, a U box-containing E3 ubiquitin ligase implicated in cancer progression and metastasis, 24 was identified (Figure 3c ). To determine whether CHIP and Slug form a complex in vivo, we examined the interaction between endogenous CHIP and Slug in lung cancer cells. The protein complexes involving CHIP and Slug could be detected in CL1-5 cells pre-treated with MG132 ( Figure 3d) . Furthermore, the interaction between ectopically expressed Flag-tagged Slug and HA-tagged CHIP was weakened by GSK3b inhibition (Figure 3e ; Supplementary  Figure 4a ), suggesting that GSK3b-mediated Slug phosphorylation enhances CHIP-Slug interaction. To investigate whether CHIP participates in Slug degradation, we knocked down CHIP by its specific shRNAs in CL1-5 cells transduced by lentiviruses. Depletion of CHIP caused a conspicuous elevation of Slug protein levels without a significant change in Slug mRNA levels (Figure 3f ), suggesting that Slug is not transcriptionally regulated by CHIP. To assess whether the inactivation of GSK3b-mediated phosphorylation sites is less associated with CHIP, we expressed Flagtagged Slug-WT or Slug-4SA in HEK293 cells. The Flag-tagged 4SA mutant abolished the interaction with endogenous CHIP, as did Flag-Slug-WT under the inhibition of GSK3b activity (Figure 3g) . Moreover, knockdown of CHIP led to the accumulation of the protein level of ectopically expressed Flag-Slug-WT, but not that of Flag-Slug-4SA, indicating that CHIP may participate in the GSK3b-mediated turnover of Slug (Figure 3h) . A well-known F-box protein, b-trcp, has been reported to have a role in many GSK3b-degraded substrates. 48 However, we did not observe any . Twenty-four hours after transfection, the cells were treated with 10 mM MG132 and 25 mM GSK3b inhibitor VIII (where indicated) for 8 h before cell collection. The lysates were subjected to immunoprecipitation using anti-Flag antibodies. Western blot analysis was conducted with the indicated antibodies to determine the protein interactions. (h) A549 cells were infected with control shLacZ or shCHIP viruses. Seventy-two hours after infection, the cells were re-seeded for the transduction with Flag-Slug-WT or -4SA lentiviruses. Forty-eight hours after transduction, the lysates were prepared and western analysis was performed. (i) A549 cells infected in (h) were transfected with the plasmid-expressing Mycubiquitin. Twenty-four hours after transfection, the cells were treated with 10 mM MG132 for 6 h before cell collection. The lysates were subjected to immunoprecipitation using anti-Flag antibodies. Western blot analysis was conducted with the indicated antibodies to determine the protein interactions. IgG, immunoglobulin G; LC-MS/MS, liquid chromatography-tandem mass spectrometry; Ub, ubiquitin.
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reporter was repressed in the presence of a Slug expression construct. This repression was alleviated in the presence of GSK3b-CA, but coexpression of GSK3b-KD enhanced the repression activity of Slug (Figure 4a ), supporting the notion that GSK3b-KD acts as a dominant-negative form of the normal enzyme. 44, 49, 50 As Slug transcriptionally represses E-cadherin, we then established stable cells expressing Slug-WT or Slug-4SA in CL1-5 or HEK293 cells by lentiviral transduction. Expressions of E-cadherin, along with two other tight-junction molecules regulated by Slug, occludin and claudin-1, were downregulated in cells overexpressing wtSlug and were further decreased in those overexpressing nonphosphorylatable Slug-4SA (Figure 4b ; Supplementary Figure 5a) . Loss of epithelial markers and induction of the fibroblast marker, vimentin, indicated that these cells underwent EMT (Figure 4b; Supplementary Figure 5a) . The Slug-4SA mutant stable cells were more motile than Slug-WT cells, as reflected by the wound-healing assay and the total displacement in the single-cell tracking assay (Figure 4c ; Supplementary Figures 4b-e) . Cell invasiveness was increased in cells overexpressing wtSlug and further enhanced in those overexpressing the nonphosphorylatable Slug-4SA mutant ( Figure 4d ). These data indicate that stabilized Slug-4SA, which abolishes GSK3b-mediated phosphorylation, can enhance cell motility and invasiveness. in Supplementary Information, Supplementary Table S1 . Among the 52 patients with NSCLC, 28 (53.8%) samples stained positive for GSK3b-pSer9, in agreement with the reports that GSK3b is highly inactivated in various tumors. 42 Slug was highly expressed in 13 out of 28 samples with GSK3b inactivation (46.4%). On the other hand, of the samples with low GSK3b-pSer9 staining, most (83.3%) displayed a low expression of Slug in patients with NSCLC (P ¼ 0.0226; Figure 6b ). Interestingly, among these 20 patients with a low Slug protein level and a low expression of GSK3b-pSer9, CHIP was highly expressed in 12 (60%) of the samples (Supplementary Figure 6a ; Supplementary Table S2), implicating that high CHIP expression may facilitate GSK3b-mediated Slug degradation in vivo.
DISCUSSION
In this study, we found a novel post-translational mechanism that controls Slug protein turnover in lung cancer. By proteomic analysis, we successfully identified GSK3b and CHIP as the components of Slug degradation machinery (Figure 6c ). As revealed by recent studies, GSK3b-mediated phosphorylation of Slug affects its protein stability, localization and functions in breast cancer. 51, 52 We found that GSK3b interacts with Slug in vivo in the CL1-5 lung cancer cell line and reduces Slug protein stability by CHIP-mediated degradation. Accumulation of nondegradable Slug, on the other hand, manifests increased migratory and invasive capabilities in lung cancer cells. These enhanced EMT functions further promote tumor metastasis, as demonstrated by the in vivo cancer metastasis mouse model, suggesting that Slug needs to be tightly controlled in tumor progression and further development of cancer metastasis.
Increasing evidence has indicated that the tumor microenvironment may provide a variety of signals to stimulate EMT, including numerous growth factors, pro-oxidant species, and cytokines. During cancer progression, these signals help reorganize the structure and composition of the connective tissue and in turn influence cancer cell functions, usually accelerating tumor growth and invasion and aggravating therapy. 53 It has been demonstrated that the phosphatidylinositol 3 kinase/Akt and extracellular signal-regulated kinases 1 and 2 signaling pathways are activated by EGF and p38 mitogen-activated protein kinase by enhanced oxidative stress, all of which induce migration and invasion mediated by the upregulation of Snail, Slug, ZEB1 and b-catenin in association with GSK3b inhibition in various cancers. 41, [54] [55] [56] [57] [58] In this study, we showed that the activity of GKS3b inversely correlates with the Slug protein level in EGF treatment or serum starvation. Treatment of an Akt inhibitor reverses such a correlation and cell morphology. Further treatment of a GSK3b inhibitor led to the accumulation of the protein level of Slug and kept the cells in their spindle-like shapes, suggesting that GSK3b may be involved in Slug degradation and the process of EMT. Interestingly, John et al. 59 have recently reported that GSK3b inhibition is associated with the decreased expressions of Slug and N-cadherin in melanoma. Although GSK3b is often considered inactivated in most cancers and deemed a tumor suppressor, this report may raise the possibility that GSK3b acts as a tumor promoter instead of a tumor suppressor in certain tumors, depending on the cell type. 60, 61 We found that in our cohort examined, active GSK3b highly correlates with Slug downregulation (83.3%). Moreover, up to 60% of patients with a low Slug level and a low GSK3b-pSer9 level have a high expression of CHIP, implying that CHIP may participate in the GSK3b-mediated Slug degradation in NSCLC. On the other hand, inactive GSK3b is partially associated with Slug overexpression (46.4%). We inferred that besides GSK3b, other mechanisms may regulate the turnover of Slug in NSCLC, such as the p53-MDM2-Slug pathway identified earlier by our group. 14 GSK3b inactivation and upregulation of Slug, however, can partially account for the clinically observed cancer progression and metastasis in patients with NSCLC.
Although E3 ligases, such as FBW7 and b-trcp, often degrade the substrates of GSK3b, their well-characterized degradation sequences (degrons) are not found within Slug, Moreover, our preliminary data showed that knockdown of neither FBW7 (data not shown) nor b-trcp affected the Slug protein level in lung cancer cell lines. We thus speculated that other E3 ligases might be involved in GSK3b-mediated Slug degradation. CHIP newly identified by the proteomic assay has been implicated in the degradation of a variety of oncogenic proteins, many of which have an important role in tumorigenesis, migration and invasion. [62] [63] [64] We found that CHIP interacts with Slug in vivo and that the interaction weakens in the presence of GSK3b inhibitor or nonphosphorylatable Slug. Knockdown of CHIP accumulates both endogenous and ectopically expressed wtSlug (but not 4SA). In addition, knockdown of CHIP reduces the ubiquitylation of wtSlug, but not that of nonphosphorylatable Slug, suggesting that CHIP degrades Slug in a phosphorylation-dependent manner. Wu et al. 52 have indicated that b-trcp participates in the GSK3b- 65, 66 A recent report reveals that loss of FBW7, but not other kinds of F-box proteins, accounts for the accumulation of Mcl-1 in T-cell acute lymphoblastic leukemia and FBW7 promotes Mcl-1 destruction in a GSK3-mediated phosphorylation-dependent manner. 67 Therefore, cells may indeed orchestrate these destruction components in the context required.
Slug has long been held as an invasion-promoter, but the posttranslational regulation of Slug has been less discussed. The inactivation of GSK3b in epithelial cancers stabilizes several oncogenic transcriptional repressors, that is, Slug, in our finding. Nonphosphorylatable Slug enhances migration and invasion; moreover, it promotes metastasis and aggravates the survival rate of the experimental models. Conacci-Sorrell et al. 68 have indicated that Slug can be transcriptionally regulated by b-catenin in a cell-density manner. Post-translational modification and protein degradation may be equally significant in modulating the amount of Slug in cells that require migration and invasionin this case, lung cancers. In summary, the finding that GSK3b phosphorylates Slug through the CHIP pathway to mediate Slug degradation may offer new therapeutic targets to prevent cancer metastasis.
MATERIALS AND METHODS
Plasmids and transfection
The Slug expression plasmids, p3xFlag-CMV-7.1-2-Slug, -S100A, -S104A, -2SA and -4SA, were constructed by cloning full-length human Slug complementary DNA into the p3xFlag-CMV-7.1-2 vector and its mutant expression plasmids were generated by site-directed mutagenesis with a QuikChange kit (Stratagene, La Jolla, CA, USA), using the primers: for S100A, forward 5 0 -CTCCTCCAAGGACCACGCTGGCTCAGAAAGCCCC-3 0 and reverse 5 0 -GGGGCTTTCTGAGCCAGCGTGGTCCTTGGAGGAG-3 0 ; for S104A, forward 
Viruses and transduction
Slug-WT and Slug-4SA were subcloned into pAS2.neo lentiviral vectors. LacZ-and GSK3a-, GSK3b-, b-trcp-, CHIP-shRNA-containing lentiviral vectors were obtained from the National RNAi Core Facility (Academia Sinica, Taipei, Taiwan) and prepared in accordance with standard protocols. In brief, HEK293T cells were co-transfected with pLKO.1-shRNA, pCMVDR8.91, and pMD.G. Virus-containing medium was collected at 24-, 48-and 72-h post-transfection. To generate the stably transduced clones, cells were infected with lentivirus in medium containing polybrene (8 mg/ ml). At 24 h after infection, cells were treated with 0.75 mg/ml puromycin or 400 mg/ml G418 to allow for the selection of a pool of antibiotic-resistant clones.
Cell culture HEK293, HEK293T and H1299, A549 cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. HOP62 and CL1-5 cells were cultured in RPMI medium containing 10% fetal bovine serum and L-glutamine. Stably transduced, pooled clones were maintained in the medium supplemented with 0.75 mg/ml puromycin or 400 mg/ml G418, as appropriate for the corresponding selection markers. For serum starvation, cells were maintained in RPMI medium without 10% fetal bovine serum. For EGF treatment, fresh medium supplemented with the indicated concentrations of EGF was added after 24-h starvation.
Cell lysate preparation, immunoprecipitation and immunoblotting
Cell lysates for immunoblotting or immunoprecipitation were prepared in IP lysis buffer (20 mM Tris pH7.5, 100 mM NaCl, 1% IGEPAL CA-630, 100 mM Na 3 VO 4 , 50mM NaF, 30 mM sodium pyrophosphate) containing 1 Â complete protease inhibitor cocktail with or without EDTA (Roche, Basel, Switzerland). For co-immunoprecipitation, H1299 cells were transfected with plasmids expressing GSK3b and Slug with the indicated tags for 24 h, and then treated with MG132 (10 mM) for 5 h. The supernatant was incubated with anti-Flag M2 antibodies overnight at 4 1C and with protein A agarose for 1 h at 4 1C. For endogenous co-immunoprecipitation, cells were cross-linked with 5 mM dimethyl 3,3'-dithiobisproprionamidate-2-HCl (Pierce, Rockford, IL, USA) at 37 1C for 30 min and Slug was immunoprecipitated by anti-Slug antibodies as described previously.
14,69 Protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to a poly(vinylidene difluoride) membrane and probed with the indicated antibodies. Proteins were detected by chemiluminescence.
Antibodies
The primary antibodies used for immunoblotting were as follows: 
Cycloheximide protein synthesis inhibition assay
The turnover of proteins was determined using cycloheximide inhibition of protein synthesis. Cells were treated with 300 mg/ml cycloheximide (Sigma) for the indicated time points.
Reverse transcriptase-PCR and real-time quantitative PCR Total RNAs were extracted by TRIzol (Invitrogen) and complementary DNAs were prepared and underwent PCR as described previously. 14 The amount of PCR products was determined by agarose gel electrophoresis in the presence of ethidium bromide. For real-time quantitative PCR, the primer sets for Slug (Hs00161904_m1) and the internal control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Hs99999905_m1), were purchased from Applied Biosystems (Foster City, CA, USA). Data were acquired using an ABI PRISM 7500 system (Applied Biosystems). The expression level of Slug relative to that of GAPDH was defined as -DC T ¼ -(C T Slug-C T GAPDH). The Slug complementary DNA/GAPDH complementary DNA ratio was calculated as 2 À DCT Â K, in which K is a constant. Experiments were performed in triplicates.
Time-lapse microscopy
Time-lapse images of migrating cells in serum-containing medium at 37 1C/5% CO 2 were taken on an inverted Zeiss Axiovert 200M microscope (Carl Zeiss, Jena, Germany) over the course of 20 h. Images were obtained with a CoolSNAP HQ CCD camera (Roper Scientific, Trenton, NJ, USA) at 15-min intervals and analyzed using MetaMorph 5.0 software (Universal Imaging, Downingtown, PA, USA).
Luciferase activity assays 
Experimental metastasis in vivo
For the in vivo tail vein metastasis assay, a single-cell suspension containing 10 6 cells in 0.1 ml of phosphate-buffered saline was injected into the lateral tail veins of ten 8-week-old non-obese diabetic-severe combined immunodeficiency mice (supplied by the Laboratory Animal Facilities in the Institute of Biomedical Sciences, Academia Sinica). After 4 weeks (CL1-5/wtSlug and 4SA mutant overexpression groups; at least eight mice per group), the mice were killed and the lungs were examined for metastasis. The lungs were removed and fixed in 10% formalin, and the number of lung tumor colonies were counted under a dissecting microscope.
Statistical analysis
Data are presented as mean±s.e.m. Comparisons of data between two groups were made with the Student's t-test. Statistical analyses were performed with SPSS software (version 10.0; SPSS, Inc., Chicago, IL, USA). All statistical tests were two-sided, and P-values of o0.05 were considered statistically significant.
